Anderson Matheus, B.Pharm. retweeted

Neurology: Clinical Practice@NeurologyCPJul 15
🇺🇸
United StatesConnected via WebAccount-level information, not a live location or per-post device.
Efficacy and Safety of Perampanel in Patients With Brain Tumor-Related Epilepsy: A Systematic Review and Meta-Analysis hubs.la/Q04nDPky0
Anderson Matheus, B.Pharm. retweeted
We strike again! Our latest study just published in Neurosurgery @CNS_Update
4,500+ patients: longer stent retrievers → better first-pass reperfusion, same complication rate.
Take-home: length matters — but let anatomy and clot guide the choice.
#neurosurgery #stroke #LVO
Anderson Matheus, B.Pharm. retweeted
🔥Hot off the press📄
Tirzepatide versus semaglutide for the prevention of mild cognitive impairment, dementia, and Alzheimer's disease in type 2 diabetes: A real-world, retrospective cohort study
sciencedirect.com/science/ar…
#diabetes #dementia #Neurology #MedTwitter #alzheimer
Anderson Matheus, B.Pharm. retweeted
Our systematic review and meta-analysis on closed-loop spinal cord stimulation for chronic pain is now published in Neuromodulation (
@IntlNeuromod )! Grateful for the guidance and support, Dr.@monaco_neuro and all team. @rafael_assilva @KenzoDonato @Andersonmhps
Anderson Matheus, B.Pharm. retweeted
Join us in Chicago or live online for the 2026 AAN Annual Meeting!
Anderson Matheus, B.Pharm. retweeted
The Main Types of Dementia and How to Spot Them bencura.com/the-main-types-o…
#Alzheimers #dementia #health
Anderson Matheus, B.Pharm. retweeted
🧬 Unlocking Hypertension: Can DNA Methylation Guide Personalized Therapy?
pubmed.ncbi.nlm.nih.gov/4072…
@eryvelton.franco @bernadete.maia @ufpe.oficial @lfpb_ufpe @saudetranslacional @dillanamaral @anderson_corin @31.livia @elainetorres.est @anamavii @andersonmhps @andersonm.rs
#Hypertension #Epigenetics #PrecisionMedicine #DNA #CardiovascularHealth

ALT Hypertension affects 1.28B adults worldwide. This review explores genetic and epigenetic biomarkers—especially DNA methylation—in blood pressure regulation. While promising signals emerge, no biomarker yet predicts clinical outcomes. More rigorous, diverse, and longitudinal studies are essential to translate these findings into truly personalized therapies for hypertension management.
Anderson Matheus, B.Pharm. retweeted
Online now: Molecular pathways and diagnosis in spatially resolved Alzheimer’s hippocampal atlas dlvr.it/TJsLXd
Anderson Matheus, B.Pharm. retweeted
Online now: A transcriptomic atlas of astrocyte heterogeneity across space and time in mouse and marmoset dlvr.it/TPN68R


















